Scientists at UBC Okanagan have revealed the mechanisms behind the production of mitraphylline, a rare compound known for its potential anti-cancer properties.
The research team identified two enzymes that collaborate to form the compound's distinctive twisted structure, which is critical to its function.
This discovery could pave the way for new approaches in cancer treatment, although further research is needed to fully understand the implications.